|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/35 | |
| A61K 9/48 | |||
| A61J 3/00 | |||
| A61J 3/07 | |||
| C07K 16/16 |
| (11) | Number of the document | 2968529 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14776121.7 |
| Date of filing the European patent application | 2014-03-12 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/024401 |
| Date | 2014-03-12 |
| (87) | Number | WO 2014/159607 |
| Date | 2014-10-02 |
| (30) | Number | Date | Country code |
| 201361784964 P | 2013-03-14 | US |
| (72) |
WALSER, Bryan, US
RAFF, Howard, V., US
|
| (73) |
Aimmune Therapeutics, Inc.,
8000 Marina Boulevard Suite 300, Brisbane, CA 94005-1884,
US
|
| (54) | MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION |
| MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION |